Group One Trading
CBAY

Group One Trading’s Cymabay Therapeutics CBAY Stock Holding History

Group One Trading’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-155,700
Closed -$3.68M – 8203
2023
Q4 		$3.68M Sell
155,700
-59,800
-28% -$1.07M 0.01% 1370
2023
Q3 		$3.21M Buy
215,500
+214,100
+15,293% +$2.84M 0.01% 1263
2023
Q2 		$15.3K Sell
1,400
-14,300
-91% -$133K ﹤0.01% 6152
2023
Q1 		$137K Buy
15,700
+14,500
+1,208% +$116K ﹤0.01% 4015
2022
Q4 		$7.52K Hold
1,200
– – ﹤0.01% 6148
2022
Q3 		$4K Sell
1,200
-3,000
-71% -$10.8K ﹤0.01% 6974
2022
Q2 		$12K Sell
4,200
-300
-7% -$717 ﹤0.01% 6677
2022
Q1 		$14K Sell
4,500
-4,500
-50% -$14.2K ﹤0.01% 7021
2021
Q4 		$30K Sell
9,000
-22,500
-71% -$85.4K ﹤0.01% 6732
2021
Q3 		$115K Sell
31,500
-10,600
-25% -$41.8K ﹤0.01% 5773
2021
Q2 		$184K Sell
42,100
-700
-2% -$3.1K ﹤0.01% 5323
2021
Q1 		$194K Buy
42,800
+11,100
+35% +$59.7K ﹤0.01% 5063
2020
Q4 		$182K Buy
+31,700
New +$240K ﹤0.01% 4122
2020
Q3 		– Sell
-110,900
Closed -$387K – 6655
2020
Q2 		$387K Buy
+110,900
New +$320K ﹤0.01% 2846
2020
Q1 		– Sell
-14,400
Closed -$28K – 5880
2019
Q4 		$28K Buy
14,400
+8,900
+162% +$33.4K ﹤0.01% 4251
2019
Q3 		$28K Sell
5,500
-600
-10% -$3.63K ﹤0.01% 4234
2019
Q2 		$44K Buy
6,100
+2,100
+53% +$23.8K ﹤0.01% 3841
2019
Q1 		$53K Sell
4,000
-2,800
-41% -$29.8K ﹤0.01% 3537
2018
Q4 		$54K Buy
6,800
+1,300
+24% +$12.4K ﹤0.01% 3528
2018
Q3 		$61K Buy
5,500
+5,300
+2,650% +$65.8K ﹤0.01% 3850
2018
Q2 		$3K Sell
200
-14,200
-99% -$178K ﹤0.01% 4909
2018
Q1 		$187K Sell
14,400
-1,700
-11% -$21.1K ﹤0.01% 2848
2017
Q4 		$148K Buy
16,100
+15,900
+7,950% +$136K ﹤0.01% 3122
2017
Q3 		$2K Sell
200
-300
-60% -$2.03K ﹤0.01% 4660
2017
Q2 		$3K Buy
+500
New +$2.13K ﹤0.01% 4529

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Group One Trading's CBAY Position: Q4 2023 in Review

Group One Trading sold out of Cymabay Therapeutics (CBAY) in Q4 2023, closing a stake of 23,495 shares — an estimated $418K sold.

Group One Trading first reported a position in CBAY in Q2 2017 and held it in 11 quarters. The position peaked at $350K in Q3 2023. 200 funds tracked by Wall St. Rank hold CBAY as of Q4 2023.

  • Group One Trading reported no remaining Cymabay Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Group One Trading sold 23,495 Cymabay Therapeutics shares in Q4 2023, an estimated $418K.
  • Group One Trading first reported a position in Cymabay Therapeutics in Q2 2017 and held it in 11 quarters.
  • Group One Trading's Cymabay Therapeutics position peaked at $350K in Q3 2023.
  • 200 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.